will be ready to dish out an Omicron-specific booster vaccine this fall, its chief medical officer has said — as U.S. Covid cases surge 51 percent over the past two weeks.
The leading vaccine manufacturer's Dr Paul Burton revealed it was now testing a shot against likely to be 'even more superior' than its current jab — with 'large amounts' set to be available as soon as this September.
All Covid vaccines are currently based on the original Wuhan virus, amid hesitancy among manufacturers to spend months making a new jab in case another variant emerges. If approved, Moderna's shot would be the first to target the Omicron variant.
Load More
Yorumlar
Kalan Karakter: